Diagnostic Imaging's Weekly Scan: July 5 — July 11

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In comparison to everolimus, the peptide receptor radionuclide therapy (¹⁷⁷Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumors (GEP NETs), according to new phase 3 research.

In a recent interview with Diagnostic Imaging, Nina Kottler, MD, offered her perspective on findings from a recent report on AI in health care, AI integration challenges and what the future holds with AI in radiology.

Researchers found that former NFL players had a 3.8-fold higher mortality rate for all-cause dementia and a nearly 3.9-fold higher mortality rate for Parkinson’s disease, according to a study involving over 19,800 former NFL players.

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses pertinent principles, pearls and outcomes with Y90 radioembolization for the treatment of patients with liver cancer.

For patients having CT angiography prior to TAVR procedures, researchers found that photon-counting detector CT (PCD-CT) offered higher specificity and PPV for detecting significant coronary artery disease (CAD), according to study findings presented at the Society of Cardiovascular Computed Tomography (SCCT) conference.